Today’s imaging systems are more powerful than ever. A single CT scan generates hundreds of cross-sections. An MRI cardiac study captures the heart in four dimensions. A full-body PET produces a dense volumetric map of metabolic activity across every organ system.

And yet, in most hospitals today, clinicians consume all of that data the same way they did in the 1990s: as 2D slices, scrolled one frame at a time, with the third dimension reconstructed entirely in the radiologist’s head.

That gap between the data that exists and the data that gets used is what 3D medical visualization is closing.

Progress hasn’t been uniform. The specialties with the highest spatial stakes have moved fastest. In oncology, where tumour margins and vascular relationships determine whether a resection is safe, 3D visualization is now routine. In cardiology, where structural defects live in three dimensions that 2D echo can only approximate, volumetric review has become standard practice for complex case planning. For these teams, rotating a segmented model or flying through a volume-rendered vessel is part of the reading workflow.

Within healthcare, oncology drives roughly 34% of total 3D imaging spend: 52% of cancer centers already use 3D imaging as part of their standard workflow, and 44% of cardiology departments do the same.

For much of medicine, the shift is still underway. But the direction is clear. The market reflects it. The global 3D medical imaging market was valued at $21.43B in 2025 and $23.39B in 2026 and is projected to reach $42.75B by 2032  at a compound annual growth rate of 10.36%. Healthcare has become the largest adopter of 3D imaging technology overall.

In this article, we break down what 3D medical visualization actually means technically and where it creates measurable clinical value.

The imaging data problem

Begin with the scanners, because they don’t produce data the same way:

1. CT measures X-ray absorption, so dense tissue like bone reads strongly while soft tissue stays faint: the default for trauma, lung, and skeletal work.
2. MRI reads tissue magnetic properties instead of density, trading speed and bone detail for soft-tissue contrast nothing else matches.
3. PET maps metabolic activity rather than structure, and almost always travels fused to a CT or MRI so the active regions have anatomy to sit against.
4. Ultrasound produces a live volume but depends heavily on probe angle and operator skill.
5. Cone-beam CT gives a tight, high-resolution field at the cost of coverage, which is why it dominates dental and interventional suites.

All of these imaging methods capture a 3D volume of the body. Yet in most cases, doctors still review that data as a series of 2D slices. At first glance, this seems surprising: why collect rich 3D data only to view it in 2D? Part of the answer is habit and established workflows, but there are also practical reasons why 2D slices remain the standard in medical imaging.

• Raw data, nothing interpreted. A slice shows the scan as acquired. Every 3D rendering is the product of decisions which densities to display, which to hide, where to set the threshold and any of those can suppress a real finding or manufacture one that isn’t there.
• Full coverage of the dataset. Scrolling slices walks the eye across every voxel in the study. A 3D view by definition hides whatever sits behind the surface it shows, and for catching a small lesion or a faint ground-glass opacity, seeing everything matters.

3D earns its place once the task moves past detection:

• Spatial relationships. 3D visualization makes it easier to understand how anatomical structures relate to one another. Instead of mentally reconstructing anatomy from dozens of 2D slices, clinicians can view organs, vessels, and abnormalities as a single 3D model.
• Change over time. Tracking changes across multiple scans becomes much easier in 3D. By measuring the volume of a structure over time, clinicians can quickly identify trends that may be difficult to spot in individual slices.
• Communication. A 3D model is something a patient, a referring physician, or a multidisciplinary team can read at a glance, where a slice stack means little to anyone outside radiology.

So, 3D visualization is most valuable when understanding spatial relationships is difficult or time-consuming in 2D.

What complicates this in practice is the format the data arrives in. Most medical imaging is still stored as DICOM, a standard built around 2D-image workflows. DICOM is the backbone of medical imaging, but several of its legacy choices make 3D visualization and analysis harder to build on top of it. Gathering everything a full analysis needs is one problem: a careful read of a pathology usually draws on prior scans and the patient’s imaging history, and that data sits scattered across separate studies and series rather than in one place. Interoperability is another. DICOM has to exchange data with the hospital’s other systems, such as PACS, RIS, and the electronic health record, and every connection point adds friction. The input itself is uneven too: scans vary in quality and completeness depending on how and where they were acquired, so a tool built for real cases has to hold up across that range. We’ve written separately about why DICOM is stuck in the ’90s.

What “3D medical visualization” actually means

There are five techniques in common use. Most clinical software uses two or three of them together. Segmentation comes first, because the others depend on it.

Segmentation. Something has to label what is in the scan before the rest can work. It needs to know which voxels are liver, which are tumour, which are vessel wall. This used to be manual work. A radiologist drew outlines on each slice, which for a complex case could take close to an hour. Two radiologists rarely produced identical outlines. AI tools changed this. TotalSegmentator and similar models label most organs in a CT scan in under a minute. The clinician checks and corrects the result instead of drawing it. This is what makes the other four techniques practical for routine use.

Multiplanar reformatting (MPR). The volume is resliced along any plane the clinician chooses, not only the axes the scanner recorded. The output is still a 2D image. But it can be cut to follow a curved vessel, or to lay a fracture flat in one view. These are angles the original scan never produced. MPR is the most common technique. It is built into every PACS, and it is usually the first step a team takes beyond plain slice reading.

Surface rendering. This turns segmented structures into solid 3D models. You can rotate them, send them to a 3D printer, or load them into an AR headset. It works well for isolated organs and for showing a patient or a student what is going on. It has one important limit. Only what was segmented exists in the model. Anything left unlabelled is not in the scene. So a surface model is only as reliable as the segmentation behind it.

Volume rendering. This renders the full voxel grid directly, without building surfaces first. Tissue densities are mapped to colours and opacities, so the clinician can look through the layers and adjust what is visible. No data is dropped. Every voxel stays available, which is why most diagnostic 3D workstations rely on it. Rendering a full volume interactively needs a capable GPU, and that requirement shapes many of the architecture decisions teams face when they build these tools.

Cinematic rendering. This is volume rendering with realistic lighting added on top. It uses soft shadows and global illumination, the same physics used in animated film. The result is easier to read. But there is a risk that comes with it. The image can look more precise than the scan actually is. 

Where 3D visualization creates value

The biggest benefits of 3D visualization appear in a few specific use cases we described below.

Longitudinal monitoring & Treatment response tracking

In oncology follow-up, the main question is how the current scan compares to the last one. Is the tumour responding to treatment, staying stable, or growing? The answer decides what happens next: continue the regimen, change it, or escalate. So the comparison needs to be reliable, and it needs to be consistent from one reader to the next.

Reading it by eye gives neither. A radiologist compares two slice stacks taken months apart and forms a judgement: bigger, smaller, about the same. Even a careful read is rough, and two readers can reach different conclusions. 3D and quantitative imaging makes this tighter. The lesion is segmented instead of estimated, measured the same way each time, and tracked across scans. A change that is unclear on slices becomes a visible trend on a chart. And because the measurements run through a fixed set of rules, the result holds up between different readers.

Case study: Stanford’s TRAC

Stanford’s 3D and Quantitative Imaging Laboratory built a program around this. Their TRAC workflow (short for Tumor Response Assessment Criteria) generates response reports from 3D imaging measurements. It uses longitudinal analysis to show a tumour’s trajectory over time, not a set of separate readings. The process runs in a set order. When a physician requests a report, a technologist sets a baseline by measuring the target lesions on the first scan and noting any non-target lesions. About three months into treatment, a follow-up scan repeats those measurements.

The data is read against standardized tumour response criteria. Each one is matched to the cancer type and the treatment. The findings are stored and can be shown as tabulated summaries, stacked charts, or galleries of snapshots taken from the DICOM images. The clinician sees the direction of the tumour’s response, with the measurements and the criteria behind it on record.

Surgical planning, navigation and analysis

Here, the idea is to let a surgeon study a patient’s anatomy in 3D before a complex operation, and in some systems to keep that 3D view in front of them during it. The same model can run across the whole procedure: planning before the operation, navigation and decision-making in the surgical theatre during it, and analysis once it is done. A surgeon who has already explored the case in 3D knows how everything fits together before the operation starts, instead of working it out from flat scans while the clock is running. In a spinal, cranial, or cardiovascular procedure, getting that spatial picture wrong can cost the patient, so the value here is high.

What sets planning apart is what the tool is used for. A planning or navigation tool for 3D visualization is used during an actual operation, and that changes everything around it. It has to be tested to a higher standard. It has to fit the way surgeons work. And because a mistake can directly affect a patient on the table, safety, clinical approval, and regulation matter from the very first day of the project.

The technical side is harder too. The software often has to display large, detailed anatomical models and raw scan data on a lightweight AR headset. The virtual model has to line up exactly with the real patient and stay lined up, even as the surgeon and their instruments keep moving. A small lag or a slight drift is a real problem in this setting.

Case study: eXtra Vision

Qualium Systems built the surgical AR platform for eXtra Vision, a medtech startup founded by a working neurosurgeon. It tackles the main problem we described above. It projects detailed 3D anatomical models onto the surgeon’s real workspace in real time, so the anatomy is right there in front of them instead of being rebuilt in their head from slices.

Qualium Systems took the project from a rough prototype to a finished, high-performance product, and most of the hard parts were about getting the 3D right. The app had to handle heavy 3D models and DICOM scan files smoothly on AR hardware. The 3D model had to sit exactly on the real workspace and stay there, which the team handled using QR-code markers to track both the instruments and the model’s position. The tracking had to stay locked on through the small, precise movements of surgery. Operating rooms can’t rely on a steady internet connection, so the team ran the rendering on a local desktop machine and streamed the finished image to the headset over a local network using WebRTC.

Clinical trials and spatial 3D viewers

The next gen solution in medical visualization is moving 3D anatomy beyond the monitor and into the clinician’s physical environment using XR devices such as Apple Vision Pro. Instead of rotating a model on a screen, users can view it at life size, enlarge it, and examine it from any angle.

This approach is particularly useful for people who already work with 3D data but are limited by traditional displays. A surgeon walks through a patient’s anatomy at full scale before operating. A patient sees their own knee and understands the problem without a radiology background. A referring physician or a multidisciplinary team inspects the same model together. And a trial team reviews subject anatomy and progression in a shared space. The value is spatial understanding.

A spatial viewer built on existing 3D outputs can support a full set of interactions against a real case:

• View anatomy at any scale. Resize, rotate, and position the model freely from life size to room scale.
• Explore structures layer by layer. Show or hide bones, cartilage, ligaments, and other anatomical components to focus on what matters.
• Visualize cartilage thickness. A color-coded overlay highlights thickness variations across the joint.
• See MRI scans in 3D context. Display MRI slices directly within the anatomical model instead of viewing them separately.
• Take measurements. Measure distances between anatomical points directly within the 3D environment.
• Compare scans over time. View baseline and follow-up scans side by side or overlaid to track changes.
• Export results. Capture images and short videos for consultations, reports, presentations, and clinical discussions.

A viewer built for education, communication, and planning stays on the non-diagnostic side, so it needs no new FDA clearance.

Case study: XR Companion (Proof of Concept)

We developed a proof of concept for a medical imaging analysis company based on its FDA-cleared 3D visualization platform, which converts 2D MRI scans into measurable 3D knee models. The solution, called XR Companion, allows these models to be viewed in immersive environments with Apple Vision Pro.

Instead of rebuilding the 3D data from scratch, the application uses the segmented models already generated by the client’s product. This made it possible to focus on the immersive AR/VR experience itself, including interacting with real patient cases in a 3D environment.

The project also includes a streamlined data pipeline, allowing new anonymized cases to be loaded within minutes rather than prepared manually for each demonstration. Because the viewer works directly with 3D meshes on the device, it remains responsive while serving as a visualization tool rather than a diagnostic system.

Education, training and research

This is one of the easiest areas for 3D medical visualization to gain adoption because it is used for education and research rather than direct patient care. Since clinicians are not making diagnoses based on these models, the regulatory requirements are much lower than in clinical settings.

In education, 3D models help students and medical professionals better understand anatomy, practice procedures, and explore virtual dissections. They also offer practical advantages over traditional cadavers, which are expensive, limited in availability, and can only be used once. Digital models can be accessed by many learners at the same time, from different locations, and reused indefinitely.

Research is another major application. 3D imaging supports anatomical studies, biomarker discovery, long-term patient monitoring, and clinical trials by making it easier to measure and analyze structures over time.

Because the barriers to adoption are relatively low, education and research are often the first areas where healthcare organizations experiment with 3D visualization before expanding its use into clinical practice.

Case study: V-Med Pro

Qualium Systems, in partnership with ViziTech USA, built V-Med Pro, a VR/MR training platform for emergency medical responders. It is a working example of surface rendering in an education setting where segmented anatomy turned into models a user can pick up and take apart.

The core of the platform is anatomy. It holds a detailed human model split into 990 distinct body parts, which users explore in VR/MR through hand gestures and a UI. They can strip the body back layer by layer, remove the skin to see the muscles, isolate the vessels to trace circulation, which stands in for the dissection a cadaver lab would offer. Each structure is a separate segmented object, so anything the user wants to study has to exist in the model as its own part. That is the trade-off of surface rendering, and at 990 parts it is a large one.

Plus, the platform runs emergency-response scenarios for up to 20 people in a shared session, with AI-driven characters built on the OpenAI API for practising communication and decision-making.

Conclusion: Building 3D medical visualization solutions

So, every modern scan is already a volume, but most of the time it is read as flat slices. For routine work, that is still the right choice. 3D becomes useful when the question is about space rather than detection: where a tumour sits next to a vessel, what shape a defect has, or how to plan an operation in advance. Segmentation, MPR, surface and volume rendering, and cinematic rendering are the techniques that make this possible. Oncology and cardiology adopted them first because they deal with spatial questions most often.

Where this is heading

The next stage changes how clinicians work with 3D. Instead of viewing a model on a monitor, they can place it in the space around them and explore it there. Four directions are taking shape:

• Immersive case review. The same data, viewed through a headset or tablet instead of on a workstation. A surgeon, radiologist, or referring physician inspects the anatomy, tissue maps, landmarks, and measurements directly in a 3D view.
• Shared review. Several people entering one virtual workspace to look together at anonymized subject anatomy, cohort progression, lesion changes, and quantitative biomarkers. This fits clinical-trial review in particular, where the data has to be read the same way across sites and reviewers.
• Site training and quality control. The trial side of imaging needs more than a viewer. It needs site qualification, acquisition training for technologists, image-upload and phantom or volunteer scans, and protocol harmonization so that every site produces comparable data. This is the groundwork that makes shared review trustworthy in the first place.
• Patient education. A 3D model lets someone see a finding as familiar anatomy rather than a stack of cross-sections. This is one of the clearest commercial uses for AR and VR.

Building it

If you are building in this space, Qualium Systems has delivered real medical 3D and XR products, from VR training to surgical AR. If you have a project in mind, get in touch. We are glad to talk it through.